Relationship between plasma inflammatory markers and platelet aggregation in patients with clopidogrel resistance after angioplasty

Angiology

Volumn 63, Issue 1, 2012, Pages 62-66

  Ge, Hailong ^a   Zhou, Yujie ^a   Liu, Xiaoli ^a   Nie, Xiaomin ^a   Wang, Zhijian ^a   Guo, Yonghe ^a   Chen, Wangjun ^a   Yang, Qing ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

clopidogrel; inflammation; platelet aggregation

Indexed keywords

C REACTIVE PROTEIN; CD40 LIGAND; CLOPIDOGREL; INTERLEUKIN 6; PADGEM PROTEIN;

ADULT; ARTICLE; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; THROMBOCYTE AGGREGATION; TREATMENT RESPONSE;

ACUTE CORONARY SYNDROME; ADULT; ANGIOPLASTY, BALLOON, CORONARY; BLOOD VESSEL PROSTHESIS IMPLANTATION; C-REACTIVE PROTEIN; CD40 LIGAND; DRUG RESISTANCE; FEMALE; HUMANS; INTERLEUKIN-6; MALE; P-SELECTIN; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; STENTS; TICLOPIDINE; TIME FACTORS;

EID: 82955194910     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319711406432     Document Type: Article

References (35)

1. Steinhubl SR, Berger PB, Mann JT, et al. Clopidogrel for the reduction of events during observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002 ; 288 (19). 2411-2420 (Pubitemid 35340537)
2. Berger PB, Steinhubl S. Clinical implications of percutaneous coronary intervention- clopidogrel in unstable angina to prevent recurrent events (PCI-CURE) study: a US perspective. Circulation. 2002 ; 106 (17). 2284-2287 (Pubitemid 35222226)
3. Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet. 2007 ; 370 (9591). 937-948 (Pubitemid 47393576)
4. Ho PM, Peterson ED, Wang L, et al. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA. 2008 ; 299 (5). 532-539 (Pubitemid 351222546)
5. Shenkman B, Matetzky S, Fefer P, et al. Variable responsiveness to clopidogrel and aspirin among patients with acute coronary syndrome as assessed by platelet function tests. Thromb Res. 2008 ; 122 (3). 336-345
6. Hancock WW, Adams DH, Wyner LR, Sayegh MH, Karnovsky MJ. CD4+ mononuclear cells induce cytokine expression, vascular smooth muscle cell proliferation, and arterial occlusion after endothelial injury. Am J Pathol. 1994 ; 145 (5). 1008-1014 (Pubitemid 24345647)
7. Welt FG, Edelman ER, Simon DI, Rogers C. Neutrophil, not macrophage, infiltration precedes neointimal thickening in balloon-injured arteries. Arterioscler Thromb Vasc Biol. 2000 ; 20: 2553-2558
8. Wilensky RL, March KL, Gradus-Pizlo I, Sandusky G, Fineberg N, Hathaway DR. Vascular injury, repair, and restenosis after percutaneous transluminal angioplasty in the atherosclerotic rabbit. Circulation. 1995 ; 92 (10). 2995-3005
9. Okamoto E, Couse T, De Leon H, et al. Perivascular inflammation after balloon angioplasty of porcine coronary arteries. Circulation. 2001 ; 104 (18). 2228-2235 (Pubitemid 33043305)
10. Ayral Y, Rauch U, Goldin-Lang P, et al. Prolonged application of clopidogrel reduces inflammation after percutaneous coronary intervention in the porcine model. Cardiovasc Revasc Med. 2007 ; 8 (3). 183-188 (Pubitemid 47332357)
11. Maurer-Spurej E, Pittendreigh C, Solomons K. The influence of selective serotonin reuptake inhibitors on human platelet serotonin. Thromb Haemost. 2004 ; 91 (1). 119-128 (Pubitemid 38120206)
12. Gurbel PA, Serebruany VL, Shustov AR, et al. Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment. J Am Coll Cardiol. 1998 ; 31 (7). 1466-1473 (Pubitemid 28273286)
13. Ruggeri ZM. New insights into the mechanisms of platelet adhesion and aggregation. Semin Hematol. 1994 ; 31: 29-39
14. Gurbel PA, Bliden KP, Hayes KM, Yoho JA, Herzog WR, Tantry US. The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting. J Am Coll Cardiol. 2005 ; 45 (9). 1392-1396 (Pubitemid 40615608)
15. Joseph B. Muhlestein. Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients. Thromb Haemost. 2010 ; 103 (1). 71-82
16. Gurbel PA, Bliden KP, Hiatt BL, O'Connor CM. Clopidogrel for coronary stenting. Response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation. 2003 ; 107 (23). 2908-2913 (Pubitemid 36736631)
17. Toutouzas K, Colombo A, Stefanadis C. Inflammation and restenosis after percutaneous coronary interventions. Eur Heart J. 2004 ; 25 (19). 1679-1687 (Pubitemid 39286632)
18. Park DW, Yun SC, Lee JY, et al. C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation. Circulation. 2009 ; 120 (20). 1987-1995
19. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000 ; 101 (15). 1767-1772 (Pubitemid 30213096)
20. Koukkunen H, Penttila K, Kemppainen A, et al. C-reactive protein, fibrinogen, interleukin-6 and tumor necrosis factor-alpha in the prognostic classification of unstable angina pectoris. Ann Med. 2001 ; 33 (1). 37-47 (Pubitemid 32238755)
21. Lindmark E, Diderholm E, Wallentin L, Siegbahn A. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. JAMA. 2001 ; 286 (17). 2107-2113 (Pubitemid 34041595)
22. Gori AM, Cesari F, Marcucci R, et al. The balance between pro- and anti- inflammatory cytokines is associated with platelet aggregability in acute coronary syndrome patients. Atherosclerosis. 2009 ; 202 (1). 255-262
23. Klinkhardt U, Bauersachs R, Adams J, et al. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease. Clin Pharmacol Ther. 2003 ; 73 (3). 232-241 (Pubitemid 36269674)
24. Storey RF, Judge HM, Wilcox RG, Heptinstall S. Inhibition of ADP-induced P-selectin expression and platelet-leukocyte conjugate formation by clopidogrel and the P2Y12 receptor antagonist AR-C69931MX but not aspirin. Thromb Haemost. 2003 ; 88 (3). 488-494
25. Klinkhardt U, Graff J, Harder S. Clopidogrel, but not abciximab, reduces platelet leukocyte conjugates and P selectin expression in a human ex vivo in vitro model. Clin Pharmacol Ther. 2002 ; 71 (3). 176-185 (Pubitemid 34271121)
26. Chew DP, Bhatt DL, Robbins MA, et al. Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein. Am J Cardiol. 2001 ; 88 (6). 672-674 (Pubitemid 32831103)
27. Vivekananthan DP, Bhatt DL, Chew DP, et al. Effect of clopidogrel pretreatment on periprocedural rise in C reactive protein after percutaneous coronary intervention. Am J Cardiol. 2004 ; 94 (3). 358-360 (Pubitemid 38962706)
28. Quinn MJ, Bhatt DL, Zidar F, et al. Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention. Am J Cardiol. 2004 ; 93 (6). 679-684 (Pubitemid 38338553)
29. Xiao Z, Theroux P. Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with acute coronary syndrome. J Am Coll Cardiol. 2004 ; 43 (11). 1982-1988 (Pubitemid 38686790)
30. Antman EM, Giugliano RP, Gibson CM, et al. Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis. Circulation. 1999 ; 99 (21). 2720-2732 (Pubitemid 29250016)
31. Quinn MJ, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa inhibitors: recognition of a two-edged sword?. Circulation. 2002 ; 106 (3). 379-385 (Pubitemid 34778965)
32. Henn V, Slupsky JR, Gräfe M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature. 1998 ; 391 (6667). 591-594 (Pubitemid 28157601)
33. Chew DP, Bhatt DL, Robbins MA, et al. Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein. Am J Cardiol. 2001 ; 88 (6). 672-674 (Pubitemid 32831103)
34. Quinn MJ, Bhatt DL, Zidar F, et al. Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention. Am J Cardiol. 2004 ; 93 (6). 679-684 (Pubitemid 38338553)
35. Antoniades C, Bakogiannis C, Tousoulis D, Antonopoulos AS, Stefanadis C. The CD40/CD40 ligand system: linking inflammation with atherothrombosis. J Am Coll Cardiol. 2009 ; 54 (8). 669-677